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The inhalation of airborne particles can lead to pathological changes in the respiratory tract. For this reason, toxicology
studies on effects of inhalable particles and fibers often include an assessment of histopathological alterations in the
upper respiratory tract, the trachea and/or the lungs. Conventional pathological evaluations are usually performed by
scoring histological lesions in order to obtain “quantitative” information and an estimation of the severity of the lesion.
This approach not only comprises a potential subjective bias, depending on the examiner’s judgment, but also conveys
the risk that mild alterations escape the investigator’s eye. The most accurate way of obtaining unbiased quantitative
information about three-dimensional (3D) features of tissues, cells, or organelles from two-dimensional physical or
optical sections is by means of stereology, the gold standard of image-based morphometry. Nevertheless, it can
be challenging to express histopathological changes by morphometric parameters such as volume, surface,
length or number only. In this review we therefore provide an overview on different histopathological lesions in
the respiratory tract associated with particle and fiber toxicology and on how to apply stereological methods in
order to correctly quantify and interpret histological lesions in the respiratory tract. The article further aims at
pointing out common pitfalls in quantitative histopathology and at providing some suggestions on how
respiratory toxicology can be improved by stereology. Thus, we hope that this article will stimulate scientists in
particle and fiber toxicology research to implement stereological techniques in their studies, thereby promoting
an unbiased 3D assessment of pathological lesions associated with particle exposure.Introduction
The inhalation of harmful particles can lead to adverse
health effects and pathological changes in the respiratory
tract. Most often noxious inhaled particles trigger a pul-
monary inflammatory response which can initiate the
development of sub-chronic or chronic pulmonary dis-
eases including pneumonitis, silicosis, asbestosis, chronic
obstructive pulmonary disease (COPD), emphysema,
asthma, fibrosis or cancer [1]. The characteristics and
severity of particle and fiber-induced pathology depend
on exposure time and concentration as well as on par-
ticle characteristics such as chemical composition, size,
structure and surface composition [2–4]. However, the
source and composition of airborne particles is vast -
including for example combustion derived particles from* Correspondence: brandenberger.christina@mh-hannover.de
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fumes, asbestos, biological particles such as pollen and
fungi as well as engineered nanomaterials of various
compositions. By dealing with the investigation of mul-
tiple physical, chemical and biological parameters at the
same time, particle and fiber toxicology becomes a chal-
lenging field. Research on respiratory particle toxicology
and risk assessment therefore attempts not only to
investigate effects of individual particles and sources, but
also effects of particle characteristics in general such as
shape, size and composition in order to promote pre-
dictability of newly generated particles [5]. This is of
particular need with the quickly emerging field of nano-
technology and the constant development of new nano-
particles (NP;<100 nm in all three dimensions, ISO/TS
27687:2008) with unknown effects.
Whereas in vitro tests are helpful for quick toxicity
screening, long term effects in the respiratory tract are
usually only assessed by in vivo toxicology studies. In
vivo respiratory toxicology studies also include the histo-
pathological analysis of the lungs to investigate adverseis article is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
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sions indicates the extent of particle toxicity and the
type of lesions provide insight into the potential mode of
action. Quantitative measurements of histopathological
changes in the lungs furthermore enable the calculation
of dose–response curves for particle toxicity estimation
in risk assessment. Conventional analysis of histopatho-
logical lesions usually includes a scoring of the tissue
lesion by one or more experienced observers, ideally
blinded to the identity of the study group. However,
comparative studies have shown that these evaluations
are prone to an interpersonal variation with a potential
bias [6, 7]. In addition, the degree of alterations has to
be large enough to be caught by the investigator’s eye.
An accurate way of obtaining quantitative information
from histological sections is by the use of stereology.
This is an unbiased approach for the quantification of
histological structures such as volume, surface area,
length and number and has become the gold standard
for quantitative microscopy in the respiratory tract [8].
The term stereology is derived from the Greek “stereos”
which means spatial and, as a branch of stochastic
geometry, the approach is based on solid mathematics
[9]. In comparison to other forms of microscopic
morphometry – the direct measurement from two
dimensional (2D) sections - stereology enables the quan-
tification of the three-dimensional (3D) characteristics of
organs, tissues, cells or organelles based on measure-
ments on 2D sections. This is achieved by i) ensuring
that each part of the organ has an equal chance of
becoming part of the analysis and by ii) applying appro-
priate test systems/probes to randomly sampled fields of
view (see following chapters). The interactions between
the structures and the test systems generate counting
events that – inserted into the corresponding stereologi-
cal equations – provide relative values of volume, sur-
face area, length or number of biological structures. By
multiplication with the reference volume (e.g. lung vol-
ume), total values are attained which are the basis for
rigorous statistical testing. This means that in compari-
son to routine histopathology where only 1–2 tissue sec-
tions are analyzed, a larger number of randomly selected
lung tissue sections is included in the evaluation (see
section for lung stereology below). Thus, this procedure
ensures an unbiased and efficient quantitative analysis of
the respiratory tract.
Traditionally, lung stereology was developed and
applied to assess the structure and function relationships
of the lungs [10–12], however, modern experimental
morphology and histopathology equally benefit from this
unbiased approach [13, 14]. Guidelines to use quantita-
tive histopathology as a biomarker in qualification stud-
ies as well as in risk assessment for occupational and
environmental health regulations point to the need ofunbiased data acquisition, hence stereology for morph-
ometry [15–17]. This review aims at providing an over-
view of different stereological techniques which can be
used to evaluate the severity of respiratory histopath-
ology in particle and fiber toxicology.
Pathology of pulmonary particle exposure
The pathology of particle and fiber toxicology in the
respiratory tract depends on the exposure source, concen-
tration, duration and individual predisposition. Acute re-
sponses to particle exposures often include pulmonary
inflammation [18]. Various kinds of particle were reported
to induce an inflammatory response as for example
combustion-derived particles - including diesel exhaust
particles [19] and ultrafine particles (< 0.1 μm in aero-
dynamic diameter) [20], engineered NP such as carbon
nanotubes, TiO2 or Ag NPs [21–23] as well as silica [24]
or asbestos [25]. Chronic particle exposure and long
term effects may include the development of chronic
obstructive pulmonary disease (COPD) [26–28], allergic
airway inflammation [29–34], fibrosis [35–38] or neo-
plasms [39–41]. In addition, recent studies have also
addressed mixed exposures; for example the potential
of airborne particles to act as an adjuvant in the devel-
opment of allergic airway disease or the effect of ozone
with combustion derived particles as in the environ-
ment [42–46]. Mixture studies include another import-
ant aspect of inhalation toxicology which will most
likely expand in the future. Table 1 and the following
paragraphs give a brief overview on lung pathologies re-
lated to particle exposure and how they could be quan-
tified by means of stereology.
Pulmonary inflammation
The extent of pulmonary inflammation and tissue dam-
age can be well addressed via pulmonary histopath-
ology, and different inflammatory parameters can be
measured by stereology, including cellular or structural
changes. Cellular changes may include the influx of
pro-inflammatory cells such as neutrophils and macro-
phages as well as cellular proliferation or apoptosis.
Severe inflammation leads to damage of epithelial or
endothelial cells and the exudation of edema fluid to
the peri-bronchovascular or alveolar septal interstitium
as well as into the alveolar lumen. Stereological
parameters which can be used to quantify pulmonary
inflammation may include the numbers of inflamma-
tory/proliferating/apoptotic cells, the volume of pul-
monary edema or surface area of damaged epithelium/
endothelium [13].
Asthma/allergic airway disease
The pathology of asthma or allergic airway disease is
characterized by airway hyper-responsiveness, reversible
Table 1 Recommended stereological parameters in different







Inflammatory cells Number of inflammatory cells
Apoptotic cells Number of apoptotic cells




Volume of edematous fluid
Thickening of
air-blood barrier
Mean thickness of epithelium,
interstitium and endothelium
in air-blood barrier (EM)
COPD Emphysema (I) Number of alveoli
Emphysema (II) Volume of alveolar airspace
Emphysema (III) Alveolar surface area














Number of inflammatory cells






Fibrosis Fibroblast hyperplasia Number of fibroblasts
Inflammatory cell
infiltration
Number of inflammatory cells
Septal thickening Mean septal thickness
Tissue scarring Volume of non-functional
parenchyma
Collagen deposition Volume of parenchymal
collagen
Cancer Cell proliferation Number of proliferative cells
Tumor cell
characteristics
Number of cells positive
for tumor marker
Metastasis (I) Volume of metastasis
Metastasis (II) Number of metastatic
nodules
Brandenberger et al. Particle and Fibre Toxicology  (2015) 12:35 Page 3 of 15airway obstruction, infiltration of eosinophils and CD4+ T
helper type 2 cells and airway remodeling [47]. Structural
changes like infiltration of inflammatory cells and airway
remodeling, which may include mucous cell metaplasia,
increased smooth muscle mass or sub-epithelial fibrosis,
serve as measures of pathological severity of asthma and
can be stereologically quantified as cellular numbers, epi-
thelial thickness, the volume of mucus in epithelial cells
or the volume of muscle mass and fibrosis [13, 48].COPD/emphysema
The development of COPD is usually triggered by con-
tinuous irritation of the lungs resulting in chronic
inflammation and airway remodeling, which lead to the
development of obstructive bronchiolitis and emphysema
[27]. Emphysema is characterized by a distal airspace en-
largement and a loss of alveoli and alveolar surface area,
which can be assessed by stereological quantification of al-
veolar number and surface area and/or number-weighted
and volume-weighted mean alveolar volume [13, 49, 50].
Obstructive bronchiolitis is assessed in a similar manner
to airway obstruction in allergic airway disease.
Lung fibrosis
Pulmonary fibrosis is characterized by inflammatory cell
infiltration, alveolar epithelial cell injury, fibroblast hyper-
plasia, collagen deposition and scar formation [51, 52].
Lung fibrosis can be analyzed by quantitative histopath-
ology at light or electron microscopic levels: At light
microscopic level for example the volume of nonfunc-
tional parenchyma (collapsed or already remodeled) ver-
sus the volume of ventilated parenchyma can be estimated
[13], or the volume of parenchymal collagen stained with
picrosirius red [53]. At electron microscopic level the
thickening of the air-blood barrier can be investigated or
the volume of various septal compartments such as colla-
gen, extracellular matrix or fibroblasts [13, 54, 55].
Cancer
Assessment of quantitative lung histopathology can help
to quantify parameters relevant to tumor development
such as the number of proliferative cells, the number or
volume of cells staining positive for tumor cell markers
or the volume or number of metastatic nodules and
carcinomas.
Quantitative histopathology
The main problem in quantitative histopathology is that
tissue sections for microscopic analysis are i) only repre-
senting a very small fraction of the whole organ and are
ii) more or less 2D. In comparison to other forms of
morphometry, which encompasses the direct on-section
2D measurement of structures, design-based stereology
takes into consideration the 3D structures of organs, tis-
sues and cells [56]. In order to obtain i) representative
information on the whole lung and not only on a single
histological section, it is important to give each part of
the lung an equal chance of being sampled. Smaller sec-
tions from different parts of the lungs are therefore
being sampled by an appropriate sampling regime such
as systematic uniform random sampling (SURS) as
shown in Fig. 1. In order to ii) correct for the loss of one
dimension (3D→2D) appropriate test systems are used
as shown in Fig. 2. Stereological estimates of parameters
Fig. 1 Lung sampling for stereology. a Lung fixation under defined inflation pressure. b Assessment of the lung volume or reference space by the
Archimedes’ principle. c Serial sections of the lung – optionally with isotropic uniform random (IUR) orientation with the orientator. d Systematic uniform
random sampling (SURS) of lung sections: in this example, every 3rd section is included in the sampling. The first section is picked at random - either by
throwing a dice or with a random number table. e If smaller samples are desired for tissue embedding a further SUR sub-sampling is performed. Again
every third tissue piece is selected here and the 1st one chosen randomly. f Selected tissue blocks are embedded for LM or TEM – optionally
with IUR orientation using the isector
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ture of interest are first calculated as densities within
their sampling space and multiplied in the end with the
volume of the reference space - usually the total lung
volume - to obtain total numbers, length, surface area or
volume per lung. For these reasons it is very important
to be aware that stereological quantification already
starts with the collection and sampling of the whole
lung.
Lung sampling for stereology
For stereological analysis, the lungs should be collected
and preserved under a controlled inflation pressure
(Fig. 1a). Uncontrolled lung inflation pressure during
lung fixation can affect the preservation of lung struc-
tures and the final lung volume, which are essential for
stereological quantification. Sampling and fixation of the
lungs is therefore recommended by either inflation
fixation via the trachea with fixative application under a
defined pressure (recommended pressure 20–25 cm of
H2O) or by vascular perfusion fixation of an inflated
lung under controlled pressure. Generally, inflation
fixation is easier to perform and well suited for the esti-
mation of many parenchymal parameters. However, per-
fusion fixation is better suited for the estimation of
vascular and intra-alveolar parameters, including mea-
surements of intra-alveolar edema. In particular, analysis
of particle deposition and distribution in the airways and
the alveolar lining layer requires the use of fixation by
perfusion to ensure that particles can be visualized
where they have been deposited. The choice of fixativessuch as paraformaldehyde or glutaraldehyde depends on
the final method of analysis: If samples are prepared for
transmission electron microscopy (TEM), a strong fixative
mixture with 1–3% glutaraldehyde is recommended, but
for immunohistochemistry, a weaker fixative containing
1–4% paraformaldehyde is suggested. Further information
on fixation techniques and embedding methods of choice
can be found in [57, 58].
The total lung volume - which represents the reference
space in most cases - can be estimated either by the
Archimedes’ principle (Fig. 1b) or by the Cavalieri method.
For the volume measurement with the Archimedes’
principle, the lungs are immersed in a glass of water
until completely covered with water, but not touching
the glass (buoyancy). The displaced volume of water
equals the volume of the lung and can be estimated by
measuring the weight of the displaced water [59]. The
Cavalieri method [60] can easily be incorporated during
the sampling of the lung (Fig. 1c and d) as described
below.
After estimating the lung volume, tissue sections of
the lungs are being sampled. As mentioned before, it is
important that each part of the lung has an equal prob-
ability of being sampled. This guarantees that all data
are gathered from a representative sample of the whole
lung. Theoretically it is therefore possible to chop the
lungs into random pieces of a desired size and independ-
ently select a desired number of tissue blocks. However,
it has been shown that systematic uniform random sam-
pling (SURS) is more efficient than independent random
sampling [61, 62]. Thereby, the lungs are continuously
Fig. 2 Structures and stereological test probes. The intersection of stereological test probes with the structure of interest provides countable events:
test point counts for volumes, test line intersection counts for surfaces, test plane transect counts for length estimation and test volume object counts
for number estimation. Note that the sum of the dimension of the test probe and the structure always equals 3. Figure adapted from [96]
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The starting point of the first cut is chosen randomly. This
ensures the randomness of the sampling. In a next step, a
subsampling with a constant sampling interval, as shown
in Fig. 1d, is done by including every 2nd, 3rd, 4th or nth
slice into the evaluation and again the first slice is chosen
randomly. The choice of subsampling depends on the lung
size (species specific) and the microscopic embedding
technique (LM or TEM). Hence more subsampling steps
are needed for TEM sampling or large lungs, whereas tis-
sue sampling of small lungs (e.g. mice lungs) at LM level
might not require any subsampling at all. As a rule of
thumb an approximate number of 10 tissue slices is rec-
ommended for an unbiased analysis [63]. However, more
important than a precise number of tissue sections is that
the variation introduced by a number of tissue sections is
not greater than among biological individuals. This
principle of accuracy versus precision is further discussed
in the section on stereological quantification. Random
choices can be made simply by throwing a dice, using a
random number table or a computer software. The sub-
sampling procedure can be repeated several times, as
shown in Fig. 1e and f, until the tissue pieces have the
desired size for embedding. In addition to the random se-
lection, the lung samples should also have a random
orientation. The lung is an anisotropic organ, meaning
that certain lung structures as for example the bronchial
tree have a particular spatial orientation. Whereas number
and volume estimation are not affected by the anisotropy
of the lung, the orientation is critical for the estimation
of surface area and length parameters - particularlyestimations of the conducting airways and the pulmon-
ary vasculature. Other pulmonary structures such as
the parenchyma have no particular spatial orientation
and can be regarded as isotropic. In order to avoid any
bias due to selective tissue orientation, isotropic uni-
form random (IUR) orientation is performed at least
once during the sampling process in all three axes. This
can be done during tissue embedding with the isector
[64] or prior to lung sectioning with the orientator
[65]. Further details on sampling techniques and sys-
tematic uniform random sampling are provided in [66].
Stereological quantification
Sampling, embedding and sectioning of the lungs for
microscopic analysis is followed by the structural meas-
urement. At this point, the three dimensional structure
is more or less reduced to a plane, two dimensional sec-
tion. This means that all structures are reduced by one
dimension: a volume is displayed as an area (3D → 2D),
an area as a length (2D→1D), a length as a transect
(1D→0D) and the zero-dimensional characteristic of a
structural number disappears, that means it is not repre-
sented in 2D (see Table 2). The principle of stereology
takes the loss of dimension into consideration and
recovers information on the lost dimension by applying
appropriate test probes to the 2D sections. During this
process all measurements are expressed as relative
values, the so-called densities. Density values are not
affected by the loss of one dimension and for example a
volume of interest per reference volume in 3D, equals
the density of the resulting area of interest per reference
Table 2 Relationship of stereological test probes and 3D structural quantification of lung pathologies in 2D microscopic images
Parameter in 3D Parameter 2D
in section
Test probe Counting event Density Final
measurements
Volume Area Test point Point (P) in test volume VV = ∑P / total number of test points Vtot = VV x V(ref)
Surface area Boundary line Test line Line intersection (I) with
surface area
SV = 2x∑I / total length of test lines Stot = SV x V(ref)
Length Transect Test plane Transect (Q) with test plane LV = 2x∑Q / total area of test planes Ltot = LV x V(ref)
Number - Disector Particle event (Q−) in test volume NV = ∑Q
− / total disector volume Ntot = NV x V(ref)
Brandenberger et al. Particle and Fibre Toxicology  (2015) 12:35 Page 6 of 15area in 2D i.e. mm2/mm2 =mm3/mm3 = 1. The same is
true for surface area densities or lengths within test
fields, i.e. mm/mm2 =mm2/mm3 =mm−1 and length
densities or transects within test fields, i.e. 1/mm2 =
mm/mm3 =mm−2. Upon multiplication with the refer-
ence volume (mm3), the densities result in volume, sur-
face area or length per lung (Table 2).
As during tissue sampling, it is important that the
microscopic fields of view (or images) for the evaluation
are chosen randomly. An effective way to ensure this is by
applying the principle of SURS. This can easily be done
manually by choosing a random starting point outside the
sample, followed by step wise left/right and up/down navi-
gation in x and y direction; a so-called meander sampling.
It is thereby important that fields of view are strictly se-
lected by chance. Anything like searching for “the greatest
lesion” or “best looking area” will create a bias and will
jeopardize the scientific value of the study. For light mi-
croscopy, there are computer-assisted programs available
to perform a random image acquisition.
To ensure an efficient and simple counting procedure,
plain geometrical probes are applied such as points, lines
or areas. The application of the geometrical probes is dis-
played in Fig. 2. The general rule for the correct choice of
the test probe is that the sum of the dimensions of the
structural parameter and the test probe equals three or
more, hence suggesting a point grid for volume, test lines
for area, a test plane for length and a test volume for num-
ber estimation. The latter can be generated by using two
thin physical sections or two optical planes from a thick
single section, an approach called disector [67] which is
explained in more detail in Examples V and VI. The geo-
metrical probes are superimposed over the acquired
microscopic images. This can also be done digitally with
stereology programs like the STEPanizer [68] or manually
by generating a transparent foil with the geometrical
probe prints which is directly placed on the captured im-
ages. The interaction of the geometrical probe with the
structure of interest generates a counting event as shown
in Fig. 2. The number of counting events is proportional
to the “amount” of the structure and the density of the test
probe and by knowing the exact dimensions of the geo-
metrical probes, the densities can be calculated as de-
scribed in Table 2.Beyond accuracy/unbiasedness, efficiency is also an
aim of stereology. Efficiency means that the precision of
the data should be balanced between the amount of
work (and at which level of the analysis to invest what
amount of work) that is needed to gather the data and
the precision that is actually needed for the purpose of
the study. In order to keep the evaluation efficient it is
important to balance the number of tissue blocks,
images and counting events in the evaluation. In general
it is recommended to generate a total of 100 to 200
counting events per structure of interest from 10 to 15
sections to have a 5–10% coefficient of error [63]. The
coefficient of error can be reduced by including a greater
number of images in the evaluation or by increasing the
density of the test probe, but most of the time it is rec-
ommended to include more tissue blocks per lung or
lungs per experiment in the evaluation instead. This is
reflected by the “Do more less well”- principle (quote by
E.R. Weibel, see [69]): it is much more efficient to in-
crease the number of organs or tissue blocks and put
less effort into investigating each field of view. The
choice of an ideal setup depends on the frequency, dis-
tribution and size of the structure of interest. For
example, for the quantification of a large, but rare lung
lesion, it is recommended to sample more images from
several tissue blocks and combine these with a coarse
test probe set, rather than using few images with a
dense test probe set. The setup of the test system
therefore varies from case to case and needs to be
designed for the purpose of the current study. It is also
worth considering at which level of sampling the lar-
gest variation occurs and increasing the sampling at
this particular level; e.g. with a high inter-individual
variation it is better to increase the number of study
subjects or with an irregular lung lesion the number of
tissue blocks etc. Details on how to calculate the coef-
ficient of error for a stereological setup can further be
found in [14, 63, 70].
Furthermore, it is worth considering that the deposition
and distribution of inhaled particles in the lung depend on
particle size and characteristics [71] and do not necessarily
follow a random distribution. Non-random particle depos-
ition could lead to site-specific lung lesions [72, 73]. A
small pilot study for qualitative characterization of the
Fig. 3 Sampling strategies for homogeneously and heterogeneously
distributed lung lesions. Systematic random sampling such as SURS
and fractionator sampling are well recommended for homogeneously
distributed lung lesions where small sample sizes are sufficient to reach
a high precision of the estimate. However, site-specific lesions might
not be adequately represented in systematic uniform random sampled
tissue or fields of view. Different sampling strategies are therefore
recommended for heterogeneous lesions in dependence on lung
lesion distribution: Focal lesions which are randomly distributed over
the whole lung are best addressed with an initial random tissue
sampling followed by the proportionator approach for image acquisition.
This enhances the efficiency greatly. If no proportionator is available, a
more rigorous image sampling is required to obtain sufficient
information as explained in Example IV for the airways. Site-specific
lesions as for example in the bronchioles are best approached with
stratified sampling in a two-step procedure within randomly sampled
histological sections. First, the volume of the compartment of interest
is estimated (for example bronchioles) and second, the lesion in the
compartment of choice. An example of such a two-step sampling is
presented in the Examples II and III for the parenchyma (protocol
paragraphs). Note that this approach is still random, though site-specific.
SURS and whole lung estimates could still be applied, but are likely to
“dilute” the effect; hence subtle pathological changes might be missed.
Region-specific lesions such as centrilobular emphysema might be more
challenging to assess. If the region-specific lesion can be defined in
both control and treated subjects, stratified sampling is recommended.
If not, but the lesion is very prominent, SURS is still a valid alternative in
combination with pathological description of the region of the lesion.
However, certain limitations of the random sampling approach need
to be recognized, particularly if the lesions are only very mild and their
region not strictly defined
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the stereological study design. With site-specific lung
lesions, whole lung SURS, although unbiased, might not
be the most efficient approach. Other sampling strategies
are therefore recommended for heterogeneous lesions
depending on the distribution of the lesion (see Fig. 3).
Two methods which are well suited to deal with site-
specific lung lesions in stereology without jeopardizing
an unbiased histopathological quantification are strati-
fied sampling [66] or the proportionator [74, 75]. The
principle of stratified sampling includes a step of sub-
division into different “strata” or compartments of the
lung. Each compartment is then sampled by SURS and
evaluated according to its content. Thereby the sampling
efficiency in a specific compartment can be enhanced and
the evaluation related to a specific compartment of inter-
est. The proportionator is another elegant approach which
combines conventional stereology with automatic image
analysis and can be applied for quantifying site-specific
lesions with an inhomogeneous distribution within the
lung. The proportionator operates at the level of image
sampling for stereological quantification by automatically
selecting a structure of interest - for example a specific cell
type stained with IHC - in proportion to its occurrence.
The quantification efficiency is increased by a proportional
oversampling of the structure of interest, with known
probability, thus an unbiased quantification is still main-
tained by correcting for the known oversampling. In com-
parison to conventional stereology, the proportionator
requires digitalization of histological slides and suitable
software for automatic image analysis. Further literature
on the theory and application of the proportionator can
be found in [74–76].
Protocols
Depending on the histopathological structure of interest,
various stereological strategies can be applied to quantify
particle induced lesions. Some examples could be a) vol-
ume of the whole lung, the parenchyma, fibrotic tissue or
specific cells, b) surface area of alveolar epithelium and
capillary endothelium, c) mean thickness of alveolar septa
or tracheobronchial epithelium and d) number of inflam-
matory cells or alveoli. Selected examples (Figs. 4 and 5)
with calculations (Table 3) are demonstrated in the follow-
ing section. Further detailed examples and calculations
can be found in [13].
Volume estimation
Example I: Lung volume by the Cavalieri method An
example for the use of test points to estimate a volume
is the Cavalieri method for the estimation of the refer-
ence volume: After sectioning of the lung into slices of
roughly the same thickness, all lung slices are placed
laterally with the same orientation. A point grid with adefined area represented by each point (a/p) is ran-
domly placed on the lung slices and the points hitting
the cut surface of the lung sections are counted
(Fig. 4a). The total number of point counts on the lung
tissue (P) is multiplied with the area per point and the
section thickness (d). The multiplication results in the
total lung volume (V(lung)) as shown in eq. 1:
V lungð Þ ¼
X
P  a=p d ð1Þ
Example II: Parenchymal volume The lung paren-
chyma represents the gas exchanging region of the lung,
including alveolar airspace and the capillary containing
Fig. 4 Example of volume and surface area estimation with stereological probes. a Lung volume estimation by Cavalieri method: a point grid
with a known area per point is superimposed over mouse lung sections. The number of points multiplied by the area per point and the slice
thickness will result in the total lung volume. b Volume estimation of parenchymal (P) and non-parenchymal (NP) lung volume by point counts.
Note that a four-fold coarse point grid was included for the counting of parenchymal points. c Volume estimation of alveolar septa (S) and
airspace (A) by point counts and estimation of alveolar surface area with line probe intersections (I). d Quantification of mucus per length of
basement membrane on AB/PAS mucus positive section (purple). The volume of mucus (M) and epithelium (E + M) is estimated with point counts
and the surface area of the basement membrane with the line probe intersections (I). A fifty-fold coarse point grid was included for the counting
of lung tissue points (L)
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and fibers can lead to severe changes in the lung paren-
chyma including fibrosis or emphysema. The value of
parenchymal volume itself does not provide sufficient
information to characterize and quantify parenchymal
lesions, but it may be used as a reasonable first impres-
sion of the extent of the lesions, particularly when it is
combined with other estimates such as alveolar surface
area or alveolar number. The lung parenchymal volume
is best quantified at a lower magnification such as 5x or
10x. After SURS image acquisition, a point grid is super-
imposed over the images and all points on the paren-
chyma (P(par)) and non-parenchyma (P(nonpar)) are
counted. The volume of the parenchyma is then calcu-
lated by dividing the number of points hitting the paren-
chyma by the number of points hitting the reference
volume (P(lung)) and multiplied by the total lung vol-
ume as shown in eq. 2. Since the ratio of parenchyma
versus non-parenchyma is around 9:1 it is recommended
to use a coarse and a fine counting grid to attain 100–
200 counting events each and to keep the workload rea-
sonable. A double test system combining a coarse and a
fine point grid as shown in Fig. 4b, can be used for this
purpose. Hereby all coarse points on the parenchyma
and all fine points on the non-parenchyma will be
counted at the same time. However, it is important tokeep the ratio of coarse to fine points in mind and
multiply the coarse points with the inverse ratio be-
fore including them in eq. 2. The same principle of
volume estimation can be applied for the quantifica-
tion of other structures as, for example the parenchy-
mal collagen in fibrotic lungs or the alveolar airspace
in lung emphysema.
V par; lungð Þ ¼
X
P parð Þ =
X
P lungð Þ  V lungð Þ
ð2Þ
Surface area and volume estimation
Example III: Alveolar volume and surface area The
total alveolar surface area gives an estimate of the func-
tional gas exchange area and is measured with test lines.
At the same time as the alveolar surface area, the alveo-
lar airway volume, the septal volume and the mean sep-
tal thickness can be estimated. The latter can directly be
derived from septal volume and surface area [77, 78] and
could be a measure of alveolar septal thickening as
occurring in interstitial lung diseases. A SURS image
sampling at a 20x magnification is recommended for this
evaluation. A test line system, as displayed in Fig. 4c, is
superimposed and the intersections (I) of the test line
segments with the alveolar septa are counted as well as
Fig. 5 Number estimation with disector. a Cell number estimation with the disector. Proliferating cells (BrdU positive) are stained with
immunohistochemistry in brown. All cells within the counting frame which are present on the reference section (a) but not on the look-up
section (a’) are counted (arrow) and vice versa. b Alveolar number estimation with the disector. Bridges (B) are counted in the reference section
(b) and look-up section (b’). Note that any bridges in touch with the red exclusion line are not included (red arrow) in the evaluation and those
in touch with the green inclusion line are (green arrow)
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as a point grid - on the alveolar lumen (P(alv)) and on
the septa (P(sept)). The total alveolar airspace volume is
calculated by dividing the number of points hitting
alveolar airspace by the total number of points hitting
the parenchymal reference area (∑(P(alv) + P(sept)) and
multiplying the result with the parenchymal lung volume
as described above. The surface density of alveolar septa
(SV(sept/par)) is calculated by relating the total number
of intersections of the test lines with alveolar septa to
the total number of points hitting the reference volume
and to the length of test line associated with each point
of the test system (l/p) as shown in eq. 3. If only one of
the line end points is used for point counting, l/p equals
the length of an individual test line segment. The total
septal surface area (S(sept,lung)) is calculated by multi-






P parð Þ  l=p
 
ð3Þ
S sept; lungð Þ ¼ SV sept=parð Þ  V parð Þ ð4Þ
The mean septal thickness (τ(sept)) can be calculated
from the septal volume density (VV(sept/par)) and the
septal surface density (SV(sept/par)) according to eq. 5.
τ septð Þ ¼ 2 VV sept=parð Þ=SV sept=parð Þ ð5Þ
Example IV: Epithelial mucous cell metaplasia Vari-
ous studies have shown that combustion-derived particles
and nanoparticles can act as adjuvants in the development
Table 3 Examples of stereological calculations
Estimation (formula) Counts (example)a Results (example)a
Cavalieri (Fig. 4a) P
P ¼ 125
a=p ¼ 3:5 mmð Þ2
d ¼ 3 mm
V lungð Þ ¼ 4594 mm3V(lung) = ∑P x a/p x d
Parenchymal Volume (Fig. 4b) P
P parð Þ ¼ 218 4 ¼ 872P
P nonparð Þ ¼ 107P
P lungð Þ ¼P P parð Þ þ P nonparð Þð Þ
¼ 979
V par; lungð Þ ¼ 4092 mm3
V nonpar; lungð Þ ¼ 502 mm3
V par; lungð Þ ¼PP parð Þ=PP lungð Þ  V lungð Þ
V nonpar; lungð Þ ¼PP nonparð Þ=PP lungð Þ  V lungð Þ
Alveolar volume, surface area and septal thickness (Fig. 4c) P
I ¼ 394P
P septð Þ ¼ 94P
P alvð Þ ¼ 333P
P parð Þ ¼ 94þ 333 ¼ 427
l=p ¼ 35 μm
VV sept=parð Þ ¼ 0:22
VV alv=parð Þ ¼ 0:78
SV sept=parð Þ ¼ 527:3 cm−1
VV sept=parð Þ ¼
P
P septð Þ=PP parð Þ
VV alv=parð Þ ¼
P
P alvð Þ=PP parð Þ
SV sept=parð Þ ¼ 2
P
Ið Þ= PP parð Þ  l=pð Þ
S sept; lungð Þ ¼ SV sept=parð Þ  V parð Þ
V alv; lungð Þ ¼ VV alv=parð Þ  V parð Þ
τ septð Þ ¼ 2 VV sept=parð Þ=SV sept=parð Þ
V alv; lungð Þ ¼ 3191:8 mm3
S sept; lungð Þ ¼ 2158 cm2
τ septð Þ ¼ 8:3 μm
Epithelial mucous cell metaplasia (Fig. 4d) P
I ¼ 294P
P mucð Þ ¼ 89P
P epið Þ ¼ 245P
P lungð Þ ¼ 396 50 ¼ 19800
l=p ¼ 35 μm
VV muc=lungð Þ ¼ 0:0045
VV epi=lungð Þ ¼ 0:012
SV bm=lungð Þ ¼ 0:85 mm−1
VV muc=lungð Þ ¼
P
P mucð Þ=PP lungð Þ
SV bm=lungð Þ ¼ 2
P
Ið Þ= PP lungð Þ  l=pð Þ
V=S muc=bmð Þ ¼ PP mucð Þ  l=pð Þ= 2PIð Þ
τ epið Þ ¼ VV epi=lungð Þ=SV bm=lungð Þ V=S muc=bmð Þ ¼ 5:3 μm3=μm2
τ epið Þ ¼ 14:1 μm
Cell numbers (Fig. 5a) P
Q− ¼ 107 both waysð Þ
n ¼ 53
A ¼ 200 250 μm2
h ¼ 5 μm
NV cell=lungð Þ ¼ 4038 mm−3
N cell; lungð Þ ¼ 18:5 106
NV cell=lungð Þ ¼
P
Q−= 2 n A hð Þ
N cell; lungð Þ ¼ NV cell=lungð Þ  V lungð Þ
Alveolar number (Fig. 5b)
N alv; lungð Þ ¼ PB= 2 n A hð Þð Þ  V lungð Þ PB ¼ 112 both waysð Þ
n ¼ 90
A ¼ 200 250 μm2
h ¼ 5 μm
NV alv=lungð Þ ¼ 2489 mm−3
N alv; lungð Þ ¼ 11:4 106
aThe values presented in the following examples are related to Figs. 4 and 5. All density calculations are multiplied with the lung volume as estimated with the
Cavalieri method in Fig. 4a to obtain estimates of volume, surface area and number of structure of interest. Note that the calculations are based on examples
from rat lungs, but results might dissent from expected values and no shrinking corrections were applied in the formulas
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feature of allergic airway disease in different species is epi-
thelial mucous cell metaplasia [79] and the quantification
of mucous cell metaplasia can serve as a measure in the
assessment of the adjuvant potential of particles in allergy
development [33, 42]. The mucosubstance in broncho-
epithelial cells can be quantified per lung as well as per
basement membrane of broncho-epithelial cells, where
the basement membrane serves as an internal reference
measure [80, 81]. A SURS image acquisition is recom-
mended at 20x magnification. Since the conducting air-
ways are part of the non-parenchymal fraction of the lung,
which is much smaller than the parenchymal fraction, a
more rigorous image sampling of 150 to 200 images might
be required or alternatively the application of theproportionator [74]. For the analysis, a line test probe is
superimposed over the images (Fig. 4d). All intersections
(I) with the bronchial epithelial basement membrane are
counted as well as all line endpoints hitting the epithelium
(P(epi)), the intracellular mucosubstance (P(muc)) and on
the lung tissue (P(lung)). A coarse sub-sampling as shown
in Fig. 4d is recommended for counting the lung points,
to maintain the evaluation efficient. If doing so, the
counted lung points need to be multiplied by the inverse
sub-sampling fraction in order to obtain the total lung
points (ΣP(lung)). The mucus density (VV(muc/lung)) is
calculated by dividing all points hitting the mucus by the
reference points (ΣP(lung)) as shown in eq. 6. The surface
density of the epithelial basement membrane (SV(bm/
lung)) is estimated as shown in eq. 7 and the volume of
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S(muc/bm) is calculated as shown in eq. 8.




P lungð Þ ð6Þ






P lungð Þ  l=p
 
ð7Þ
V=S muc=bmð Þ ¼
X







The mean thickness of airway epithelium (τ(epi)) – a
measure of epithelial hyperplasia and hypertrophy - can
furthermore be calculated by dividing the volume density
of epithelial cells by the surface density of the basement
membrane as shown in eq. 9.
τ epið Þ ¼ VV epi=lungð Þ=SV bm=lungð Þ
¼
X







Number estimation with the disector
Number estimation can be used to quantify discrete
objects or “particles” such as cells or alveoli. As men-
tioned before, each structure is reduced by one dimen-
sion in a 2D microscopic section and a discrete object is
not represented/countable any more in a thin single sec-
tion. In order to compensate for the loss of dimension, a
disector pair is used, consisting of two (usually consecu-
tive) sections with a known distance height (h) [67, 82].
These sections can either be generated from two thin
physical sections (physical disector) or optical sections
(from z-stack images; optical disector). The latter might
be obtained by focusing and imaging through one thick
light microscopic section [83] or by selecting optical
sections from a 3D tomography [84]. Particularly laser
scanning microscopy (LSM) is very well suited for the
application of the optical disector, since image z-stacks
naturally generate multiple disector pairs [83, 85].
Thereby, a volume will be recreated – which is the vol-
ume between the surface of the first and the surface of
the second section. As discrete objects with an easy
and regular surface topology (such as cells or nuclei)
have only one beginning or end in vertical height, the
number of tops or bottoms contained in the volume be-
tween the two sections is proportional to the number
of objects within a unit of the reference volume. The
criterion to count an object in a disector is that it is
present in one section (reference section) but not in the
other section (look-up section). The distance between
the two sections of a disector – the disector height -
should be roughly one third of the average object size
and not larger than the smallest particles, otherwise theobject may be lost between the two sections. The vol-
ume reconstruction for object counting requires the
knowledge of the distance (h) between the two sections
and an area wherein the objects are counted. The
counting area is specified by an unbiased counting
frame [86] of a known area (A) and only cells within
the frame are part of the evaluation. To avoid any over-
or under-sampling in the test field area, the unbiased
counting frame consists of two inclusion and two ex-
clusion lines and their extensions (green and red in
Fig. 4a and b, respectively). Any cells touching the ex-
clusion line are omitted from the evaluation whereas
the cells touching the inclusion line are counted. Fur-
ther theoretical and practical details on the disector
can be found in [13, 63, 67].
Example V: BrdU positive cell counts An application
of the disector is the estimation of the number of par-
ticular cells of interest in the lung. Especially the number
of inflammatory cells could be useful for analyzing the
effects of particle and fiber exposure. Another potentially
relevant example is the quantification of proliferative
cells as a result of injury and repair which can be visual-
ized by Bromodesoxyuridine (BrdU) application and im-
munohistochemistry [82]. Figure 5a shows a disector
pair of lung parenchyma stained for BrdU positive prolif-
erative cells. The cells present in the reference section
(Fig. 5a), but not in the look-up section (Fig. 5a’), are
marked with arrows. Only the BrdU positive cells are
counted which are not present in the look-up section
(for example 5 counts in Fig. 5a and 3 counts in Fig. 5a’).
The test field is specified by an unbiased counting frame
[86] of a known area (A) and only cells within the frame
are part of the evaluation. The red line of the counting
frame marks the forbidden line and any cell in touch
with the red line is excluded from the evaluation
whereas the cells on the green line are included. The
numerical cell density (NV(cell/lung)) is then calculated
by dividing the number of counting events (Q−) by the
number of evaluated test fields (n), the counting frame
area (A) and the distance height between the disector
pairs (h) as shown in eq. 10. The number of test fields
(n) on the lung tissue can be estimated for example by
counting all edges of the counting frame hitting the
lung tissue and dividing the obtained counts by four.
NV cell=lungð Þ ¼
X
Q−=ðn A hÞ ð10Þ
If the cellular profiles are counted both ways (as
shown in Fig. 5a) the resulting density needs to be fur-
ther divided by two. The total number of BrdU positive
cells in the lung is obtained by multiplying the numerical
cell density by the total lung volume.
Brandenberger et al. Particle and Fibre Toxicology  (2015) 12:35 Page 12 of 15Example VI: Alveolar number The loss of alveolar
number is a measure for the development of emphy-
sema as for example in cigarette smoke induced COPD
[87]. The estimation of the numerical density and the
total number of alveoli in the lung can be achieved with
the disector method. The alveolar number is estimated
by counting the alveolar openings – which represents a
single event per alveolus - at the level of the free septal
edges, where they form a two-dimensional network
[88]. The alveolar network and number can further be
estimated with the Euler number [88, 89]. The Euler
number (χ) is obtained by subtracting “Bridges” (B) from
“Islands” (I) and “Holes” (H) [90]. A bridge is a structure
which connects two alveolar septa and closes an open
alveolus as shown in Fig. 5b. Islands and holes can be dis-
regarded in the alveolar network. Note that bridges which
touch the exclusion line or its extension are not included
in the evaluation (Fig. 5b’ red arrow) but those touching
the green inclusion line are part of the evaluation (Fig. 5b
green arrow). The alveolar numerical density (NV(alv/
lung)) is calculated by dividing the number of bridges (B)
by the total test volume as described in Example V and
shown in eq. 11. Again, if counts are performed both
ways, the density needs to be divided by two. The total al-
veolar number per lung is obtained by multiplying the al-
veolar density number with the total lung volume
(V(lung)). More information and details on the Euler con-
nectivity in lung stereology can be found in [88, 89].
NV alv=lungð Þ ¼
X
B=ðn A hÞ ð11Þ
Particle deposition and uptake in lung cells
In addition to quantitative histopathology, stereology
can also be applied to quantify particle distribution and
uptake in lung cells or cell cultures [91–93]. To estimate
the deposition and uptake of particles in the lung, the
particle number or volume distribution within the lung,
at organ, tissue, cellular or organelle level can be quanti-
fied by relating their occurrence within a specific com-
partment of interest to the volume of this compartment.
This stereological approach is called relative deposition
index [94]. However, particles must be unambiguously
identifiable in the tissue or cells by the microscopic
techniques of choice [95]. The microscopic technique of
choice is dependent on particle characteristics and may
include polarized LM, LSM, TEM or energy filtered
TEM (reviewed in [58]). Some particle types may not be
suited for microscopic quantification at all due to poor
visualization and limited resolution capacities.
Challenges and pitfalls
It is important to note that unbiased stereological data
can only result from unbiased data acquisition. Mostpitfalls resulting in biased data acquisition occur during
sample preparation, e.g. lung fixation, reference space
measurement or tissue embedding and sectioning [96].
Some pitfalls which require particular attention are listed
below:
1) Controlled lung inflation: Uncontrolled inflation
during the fixation of the lungs results in distortion
of dimensions and hence biased quantification. To
avoid such artifacts, the inflation pressure of the
lung needs to be monitored during fixation - either
by controlling the pressure of fixative application
during inflation fixation or by monitoring the air
and perfusion pressure in the lungs during perfusion
fixation. The lungs might be immersed in fixative for
a couple of hours or days till further processing to
ensure complete fixation of the tissue. It is
recommended to keep the preservation time in
fixative constant within an experiment to avoid
structural changes over time.
2) Measuring the reference space: A missing reference
space or lung volume estimation furthermore
eliminates the possibility of total lung structure
measurements and only allows relative
measurements. Interpretations based on ratio
densities, without knowledge of changes in the
reference space (the so-called reference trap) are
frequent and can be misleading [97]. It is therefore
most important to never forget to measure the
reference space.
3) Unbiased tissue sampling: An unbiased random
sub-sampling of the lungs is crucial to ensure that
every part of the lung has an equal chance of being
sampled. Furthermore, it is important to keep in
mind that surface and length estimations also require
spatial random orientation. Random orientation in
space can be acquired for example by the isector [64]
or the orientator [65].
4) Tissue deformation: All quantitative parameters are
distorted by tissue deformation. Certain fixatives and
embedding media such as formalin fixation and
paraffin embedding are prone to result in tissue
shrinkage and deformation. There are different
solutions to circumvent this problem such as using
different fixatives and embedding media or
monitoring the extent of shrinkage. Fixatives and
resins as used in TEM embedding present less tissue
shrinkage [57]. However, certain stains and section
preparations might not work on glutaraldehyde fixed
and resin embedded samples. Alternatively it is
recommended to monitor tissue shrinkage. This can
be done by embedding a tissue piece of known
dimensions and tracking the extent of shrinkage over
the embedding and sectioning process. The percent of
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application of density calculations in all dimensions.
Further information on the issue of tissue shrinking in
stereological measurements can be found in [98].
5) Biopsies: Particularly in human lung pathology
often only small biopsy samples are available. Lung
biopsy samples require a special handling since they
do not meet most criteria for lung stereology:
biopsy sites are usually non-random, the tissue
might be collapsed, tissue fixation and preparation
might be compromised due to specific require-
ments for diagnostic analysis and the reference
space is restricted to the biopsy and not the whole
organ [8]. All these constraints are a limitation for
conducting unbiased stereology. However, some
principles of stereological measurements can still be
applied for relative structural quantification.
Measurements can be performed by applying a
suitable internal reference space and stereological
test probes can be applied to quantify the structures
of interest. Further details or examples on how to
handle biopsies can be found in [99–101].
Conclusions
The severity and mode of action of noxious particles and
fibers as well as other inhalative toxicants can be assessed
with pulmonary histopathology. For this reason pulmon-
ary histopathology serves as an important instrument in
toxicity studies and for risk assessment. With the use of
stereology, histopathological lesions can be quantified in
an efficient, yet unbiased manner, allowing the creation of
dose response curves and estimating effect levels based on
lesions and pathologies. In combination with computer
programs designed for stereology the quantification can
be further facilitated. The current review aimed to provide
an overview on different particle and fiber associated
lung pathologies and how stereology can be imple-
mented in their quantitative evaluation. The examples
given serve as an illustration on how to approach stere-
ology in respiratory toxicology, and common pitfalls in
quantitative histopathology are discussed. We hope
that this article will stimulate scientists in particle and
fiber research to implement stereological techniques in
their studies in order to improve the quality of mor-
phometric quantification.
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